开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Xiaodong Lyu, Richard Y Zhao and Qing Chen
Recent advances in disease pathogenesis and modern technologies are gradually transforming conventional medicine into personalized medicine. The personalized approach to diagnosis of leukemic patients consists of comprehensive and individualized evaluation based on characteristics of the tumor cell morphology, immunophenotype,cytogenetic and molecular aberrations as well as the patient’s overall genetic make-up. Such a diagnostic approach, in addition to guiding individualized treatment, will help to identify new molecular targets for therapy.